Literature DB >> 11206586

Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy.

K Weissenborn1, G Berding, H Köstler.   

Abstract

A patient suffering from liver cirrhosis presented with a bradykinetic-rigid syndrome suspected as Parkinson's disease. A detailed work-up of the case revealed hepatic encephalopathy as the cause of the neurological symptomatology. An alteration of striatal dopamine D2 receptor binding and dopamine re-uptake sites was demonstrated by 123I-iodobenzamide (IBZM) and 123I-beta-CIT single photon emission computed tomography (SPECT), respectively. It is suggested that the alteration of the dopamine re-uptake in cirrhotics may be the cause of an increased catabolism of dopamine in HE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11206586     DOI: 10.1007/bf02674526

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  8 in total

1.  Polysomnographic sleep aspects in liver cirrhosis: a case control study.

Authors:  Vinicius Vasconcelos Teodoro; Mauricio Augusto Bragagnolo; Ligia Mendonça Lucchesi; Daniel Cavignolli; Marco Túlio de Mello; Mario Kondo; Sergio Tufik
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

2.  Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: a clinical rating scale.

Authors:  Sergei Mechtcheriakov; Ivo-W Graziadei; André Kugener; Julia Wiedemann; Chantal Galbavy; Hartmann Hinterhuber; Josef Marksteiner; Wolfgang Vogel
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

3.  IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies.

Authors:  Ralph Buchert; Georg Berding; Florian Wilke; Brigitte Martin; Daniel von Borczyskowski; Janos Mester; Winfried Brenner; Malte Clausen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-14       Impact factor: 9.236

4.  Selective alterations of brain dopamine D(2) receptor binding in cirrhotic patients: results of a (11)C-N-methylspiperone PET study.

Authors:  Yuki Watanabe; Akinobu Kato; Kei Sawara; Roger F Butterworth; Toshiaki Sasaki; Kazunori Terasaki; Koichiro Sera; Kazuyuki Suzuki
Journal:  Metab Brain Dis       Date:  2008-08-07       Impact factor: 3.584

Review 5.  Parkinsonism in cirrhosis: pathogenesis and current therapeutic options.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2012-10-20       Impact factor: 3.584

6.  Neuronuclear and Neuromelanin-Sensitive Imaging for Acquired Hepatocerebral Degeneration with Parkinsonism.

Authors:  Takashi Ogawa; Kotaro Ogaki; Yuko Mori; Hikaru Kamo; Akira Uchiyama; Koji Kamagata; Masanori Nagaoka; Nobutaka Hattori
Journal:  Mov Disord Clin Pract       Date:  2021-03-26

7.  Aberrant resting-state corticostriatal functional connectivity in cirrhotic patients with hyperintense globus pallidus on T1-weighted MR imaging.

Authors:  Xi-Qi Zhu; Hua-Jun Chen; Yu Wang; Ying Cui; Gao-Jun Teng
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 8.  Recent Updates on Acquired Hepatocerebral Degeneration.

Authors:  Hae-Won Shin; Hee Kyung Park
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-09-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.